Prednisolone Trial in Children Younger Than 4 Years

PHASE3CompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

July 1, 2015

Primary Completion Date

October 31, 2020

Study Completion Date

October 31, 2021

Conditions
Nephrotic Syndrome
Interventions
DRUG

Prednisolone

Prednisolone for 12 weeks as follows 30 mg/m2 on alternate days for 4 weeks 20 mg/m2 on alternate days for 4 weeks 10 mg/m2 on alternate days for 4 weeks

Trial Locations (5)

28207

Levine's Children/Carolinas HealthCare System, Charlotte

48109

University of Michigan Department of Pedatric Nephrology, Ann Arbor

90048

Cedars-Sinai Medical Center, Pediatric IBD & Pediatric Nephrology, Los Angeles

94305

Stanford University Medical Center, Department of Pediatrics, Division of Nephrology, Stanford

110029

All India Institute of Medical Sciences, New Delhi

All Listed Sponsors
collaborator

NephCure Accelerating Cures Institute

UNKNOWN

collaborator

University of Michigan

OTHER

collaborator

Department of Biotechnology, Government of India (funding agency)

UNKNOWN

lead

All India Institute of Medical Sciences

OTHER

NCT03141970 - Prednisolone Trial in Children Younger Than 4 Years | Biotech Hunter | Biotech Hunter